Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

AGM Statement

31 Jul 2008 07:00

RNS Number : 2540A
Halma PLC
31 July 2008
 



HALMA p.l.c.

AGM Trading Update / Interim Management Statement

31 July 2008

Halma, the leading safety, health and sensor technology group, is holding its 114th AGM later today, at which Geoff Unwin, Chairman, will make the following statement. This announcement comprises the Group's Interim Management Statement relating to the period 30 March - 31 July 2008 and includes the first quarter's trading.

"Revenue and order intake for the first quarter of this financial year showed good growth over last year, which is in line with the Board's expectations.

"Underlying organic growth in all three Halma sectors (Infrastructure Sensors, Health & Analysis and Industrial Safety) was boosted further by a positive impact from currency movements of approximately 3%. In addition, Riester, the German medical instrumentation business acquired in December 2007, has performed well.

"We continue to see opportunities for sustained growth in our existing markets both organically and via acquisitions. This reflects our successful strategy of operating in diverse markets underpinned by resilient growth drivers such as the demand for energy and water resources, increasing demand for healthcare, rising expectations of health and safety and long term demographic trends.

"Our investment in building our business in developing markets continues. The new Halma 'hub' in Mumbai will be operational in October 2008 providing an important platform for more of our businesses to grow their commercial and technical presence in India. In Shanghai, the Halma manufacturing hub will be ready for occupancy in October 2008, enabling four more businesses to establish local product assembly and procurement in the Chinese market. Over the medium term, we expect the demand for our safety, health and environmentally related products to increase in both of these key territories.

"The Group's financial position continues to be strong and there have been no material events or transactions affecting the Group.

"As stated at the time of our year end results in June, the Board believes that Halma is well positioned to make further progress in the current year and beyond."

For further information, please contact:

Halma p.l.c.

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

Tel: +44 (0)1494 721111

Hogarth Partnership Limited 

Rachel Hirst/Andrew Jaques

Tel: +44 (0)20 7357 9477

Notes:

1.

The half-yearly results for the period to 27 September 2008 are expected to be released on 27 November 2008.

2.

This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Halma p.l.c., in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

3.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMFKKKQPBKDPON
Date   Source Headline
28th May 20267:15 amRNSExecutive Board changes
13th Apr 20267:00 amRNSAcquisition
12th Mar 20267:00 amRNSTrading Update
13th Jan 20269:18 amRNSDirector/PDMR Shareholding
9th Jan 20261:26 pmRNSDirector/PDMR Shareholding
9th Jan 20267:00 amRNSAcquisition
5th Dec 20257:00 amRNSAcquisition
20th Nov 20257:00 amRNSHalf Year Results
1st Oct 20252:00 pmRNSDirector/PDMR Shareholding
26th Sep 202510:19 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTrading Update
26th Aug 20257:00 amRNSAcquisition
24th Jul 20252:15 pmRNSResult of AGM
30th Jun 202511:30 amRNSDirector/PDMR Shareholding
25th Jun 20258:30 amRNSAGM - Revised Form of Proxy
24th Jun 20259:20 amRNSDirector/PDMR Shareholding
20th Jun 20255:15 pmRNSAnnual Financial Report
18th Jun 20254:47 pmRNSDirector/PDMR Shareholding
12th Jun 20257:00 amRNSFull Year Results
16th May 20257:00 amRNSDirectorate Change
28th Mar 20251:10 pmRNSDirector/PDMR Shareholding
21st Mar 20252:00 pmRNSDirectorate Change
13th Mar 20257:00 amRNSTrading Update
28th Feb 20254:29 pmRNSDirector/PDMR Shareholding
14th Jan 20252:05 pmRNSDirector/PDMR Shareholding
8th Jan 20257:00 amRNSAppointment of Chief Financial Officer
28th Nov 202410:04 amRNSDirector/PDMR Shareholding
22nd Nov 20243:30 pmRNSDirector/PDMR Shareholding
22nd Nov 20243:26 pmRNSDirector/PDMR Shareholding
21st Nov 20247:00 amRNSHalf Year Results
18th Nov 20247:00 amRNSAcquisition
6th Nov 20242:34 pmRNSDirector Declaration
2nd Oct 20249:20 amRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSTrading Update
24th Sep 20249:45 amRNSDirector/PDMR Shareholding
3rd Sep 20249:15 amRNSPDMR Shareholding
25th Jul 20241:51 pmRNSResult of AGM
24th Jul 20249:15 amRNSDirector/PDMR Shareholding
17th Jul 202412:46 pmRNSDirector Declaration
1st Jul 20249:51 amRNSDirector/PDMR Shareholding
27th Jun 20247:00 amRNSAcquisition
25th Jun 20243:00 pmRNSDirector/PDMR Shareholding
24th Jun 20245:26 pmRNSAnnual Financial Report
13th Jun 20247:00 amRNSFull Year Results
1st May 20247:00 amRNSAcquisition
19th Mar 20243:53 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTrading Update
4th Mar 20247:00 amRNSAcquisition
21st Feb 20244:17 pmRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.